Not a single study
Story checked
Long-term endocrine therapy adherence remains low after breast cancer surgery (opens in a new tab)
news-medical.net · 2026-09-27
Short answer
Not a single studyNo clear answer.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Long-term endocrine therapy adherence remains low after breast cancer surgery
news-medical.net · 2026-09-27
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
This story isn't reporting one study.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Open claim evidenceSearch result
No single source study.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 4Not checkedA large U.S. insurance claims analysis indicates that many patients with early-stage breast cancer do not consistently maintain the long-term hormone therapy prescribed after lumpectomy.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 4Not checkedThe article says the results are relevant to discussions about omitting radiation therapy after lumpectomy, because that approach assumes patients will continue endocrine therapy for several years.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 4Not checkedFewer than 30% of patients remained above a standard adherence threshold during all five recommended years of endocrine therapy.View evidenceHide evidence
As statedfewer than 30%
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 4Not checkedPatients who did not receive radiation therapy were more likely to experience substantial lapses in endocrine therapy adherence than those who did, and younger age was also associated with lower adherence.View evidenceHide evidence
As statedtwice as likely at the 50% threshold; 20% to 25% higher risk for patients younger than 60
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Crossref, Europe PMC · 15 candidate papers
Five-year outcomes of partial breast proton beam therapy without lumpectomy for early-stage breast cancer: an interventional prospective study.
Breast Cancer (Tokyo, Japan) · 2026 · PubMed
425 Poster Retrospective analysis of 108 intraductal breast cancer treated by lumpectomy and radiation therapy
Radiotherapy and Oncology · 2002 · Crossref
Ultra-Hypofractionated Radiotherapy in Breast Cancer Before and After COVID-19.
American Journal of Clinical Oncology · 2026 · PubMed, Europe PMC
Adjuvant Endocrine Therapy Omission Increases Risk for Death by 25% in ER-Low Breast Cancer
Default Digital Object Group · 2024 · Crossref
Change in practice patterns over time for endocrine therapy and radiation therapy in women with breast cancer age 65 and older.
2026 · Europe PMC
And 10 more candidates considered.